We are live on
!
Find out more
C4 Therapeutics
CCCC
CCCC
101 hedge funds and large institutions have $153M invested in C4 Therapeutics in 2025 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
386% more call options, than puts
Call options by funds: $738K | Put options by funds: $152K
132% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 19
50% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 16
31% more capital invested
Capital invested by funds: $117M → $153M (+$35.9M)
8.57% more ownership
Funds ownership: 73.82% → 82.39% (+8.6%)
4% more funds holding
Funds holding: 97 → 101 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
101
Holders Change
+4
Holders Change %
+4.12%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
24
Increased
44
Reduced
19
Closed
16
Calls
$738K
Puts
$152K
Net Calls
+$586K
Net Calls Change
+$425K
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$9.07M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$7.7M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
-$2M |
| 4 |
Millennium Management
New York
|
-$1.77M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$1.2M |
